Northwestern on the front lines in the fight against the coronavirus
We have been battling a global crisis for a year, and Northwestern faculty, staff, students and alumni continue to step up in response to the coronavirus pandemic.
From high-impact research, drug trials and innovative new projects, scientists are helping mitigate COVID-19. In our communities, experts and volunteers are pitching in, performing tasks large and small to help lift up neighbors and those in need. On campus, the fabric of the University community is being remade in the digital space so everyone can work, learn and laugh together in ways that feed the soul and sustain us all.
Read about everything that is happening at Northwestern.
A new COVID-19 antibody blood test developed by Northwestern scientists requires only a single drop of blood self-collected at home. It could generate estimates of herd immunity, measure vaccine effectiveness and model the course of future waves of infection.
Northwestern Medicine has identified the first case in Illinois of the COVID-19 variant called P.1., which was first found earlier this year in travelers from Brazil during routine airport screening in Tokyo, Japan.
Muscle soreness and achy joints are common COVID-19 symptoms. But for some, the symptoms are more severe, long lasting and even bizarre. Northwestern Medicine illustrates the causes of these symptoms through radiological imaging.
Scientists race to mitigate coronavirus
Northwestern researchers have put their wearable COVID-19 monitoring device through a flurry of tests, updates and improvements since unveiling it in 2020. Now it has received $2.4 million from the U.S. Department of Defense for continued development.
Called DeepCOVID-XR, the machine-learning algorithm outperformed a team of specialized thoracic radiologists — spotting COVID-19 in X-rays about 10 times faster and 1-6% more accurately.
As antibody testing ramps up across the country, Northwestern researchers have developed a new method for antibody testing for SARS-CoV-2, the virus that causes COVID-19. The method requires only a single drop of blood collected from a simple finger prick.
Northwestern synthetic biologists have received funding to develop an easy-to-use, quick-screen technology that can test for infectious diseases like COVID-19. Similar to a pregnancy test, the tool uses one sample to provide a quick negative or positive. By simplifying a test, researchers could put diagnostics into the hands of people everywhere.
A global surveillance system has been developed which can dynamically track not just where the virus is now, but where it is going, how fast it will arrive and whether or not it is accelerating.
A team of researchers has created a computer model that accurately predicted the spread of COVID-19 in 10 major cities this spring by analyzing key factors that drive infection risk.
A Northwestern Medicine home-monitoring program enables doctors to catch patients before their condition deteriorates, which improves their ability to treat them if they need to go to the emergency department.
Family enterprises have had to balance economics and their legacy as they made tough decisions such as layoffs, furloughs and changing business models during the pandemic. With the economy poised for strong growth this year, these businesses now must take a long-term view to position themselves through recovery and beyond. Read the essay by Jennifer Pendergast >
Published: April 26, 2021. Updated: April 26, 2021.
Back to top